Biomaterials.info

powered by FreeFind

US Food and Drug Administration (FDA) - Inactive Ingredients

FDA Inactive Ingredients - Updated May 2006

What is the purpose of the Inactive Ingredients Database?

The Inactive Ingredients Database provides information on inactive ingredients present in FDA-approved drug products. This information can be used by industry as an aid in developing drug products. For new drug development purposes, once an inactive ingredient has appeared in an approved drug product for a particular route of administration, the inactive ingredient is not considered new and may require a less extensive review the next time it is included in a new drug product. For example, if a particular inactive ingredient has been approved in a certain dosage form at a certain potency, a sponsor could consider it safe for use in a similar manner for a similar type of product.
FDA Devices
FDA Inactive Ingredients
FDA Inactive Ingredients
FDA Inactive Ingredients


First Page Previous Page Next Page Last Page
Inactive Ingredient Route / Dosage Form
POTASSIUM CHLORIDE OPHTHALMIC; SOLUTION, DROPS
POTASSIUM CHLORIDE OPHTHALMIC; SUSPENSION
POTASSIUM CHLORIDE ORAL; CAPSULE
POTASSIUM CHLORIDE ORAL; SUSPENSION
POTASSIUM CHLORIDE ORAL; TABLET
POTASSIUM CHLORIDE ORAL; TABLET, DELAYED RELEASE
POTASSIUM CITRATE ORAL; SOLUTION
POTASSIUM CITRATE ORAL; SUSPENSION
POTASSIUM CITRATE TOPICAL; AEROSOL
POTASSIUM CITRATE TOPICAL; EMULSION, AEROSOL FOAM
POTASSIUM HYDROXIDE INTRAVASCULAR; SOLUTION
POTASSIUM HYDROXIDE INTRAVENOUS; INJECTION
POTASSIUM HYDROXIDE IV(INFUSION); INJECTION
POTASSIUM HYDROXIDE ORAL; CAPSULE
POTASSIUM HYDROXIDE ORAL; CAPSULE, SOFT GELATIN
POTASSIUM HYDROXIDE ORAL; CAPSULE, SOFT GELATIN LIQUID-FILLED
POTASSIUM HYDROXIDE ORAL; PASTILLE
POTASSIUM HYDROXIDE ORAL; SOLUTION
POTASSIUM HYDROXIDE TOPICAL; EMULSION, AEROSOL FOAM
POTASSIUM HYDROXIDE TOPICAL; EMULSION, CREAM
POTASSIUM HYDROXIDE TOPICAL; SOLUTION
POTASSIUM HYDROXIDE VAGINAL; EMULSION, CREAM
POTASSIUM HYDROXIDE VAGINAL; SUPPOSITORY
POTASSIUM METABISULFITE AN,INFILTRATION; INJECTION
POTASSIUM METABISULFITE AURICULAR (OTIC); SOLUTION
POTASSIUM METABISULFITE AURICULAR (OTIC); SOLUTION, DROPS
POTASSIUM METABISULFITE AURICULAR (OTIC); SUSPENSION
POTASSIUM METABISULFITE IM - IV; INJECTION
POTASSIUM METABISULFITE INTRAVENOUS; INJECTION
POTASSIUM METABISULFITE IV(INFUSION); INJECTION
POTASSIUM METABISULFITE IV(INFUSION); SOLUTION, INJECTION
POTASSIUM METABISULFITE NERVE BLOCK; INJECTION
POTASSIUM METABISULFITE RECTAL; ENEMA
POTASSIUM METAPHOSPHATE ORAL; SUSPENSION
POTASSIUM PHOSPHATE, DIBASIC INTRA-ARTICULAR; INJECTION
POTASSIUM PHOSPHATE, DIBASIC INTRAMUSCULAR; INJECTION
POTASSIUM PHOSPHATE, DIBASIC INTRAVENOUS; SOLUTION
POTASSIUM PHOSPHATE, DIBASIC IV(INFUSION); INJECTION
POTASSIUM PHOSPHATE, DIBASIC ORAL; CAPSULE
POTASSIUM PHOSPHATE, DIBASIC ORAL; POWDER, FOR SUSPENSION
POTASSIUM PHOSPHATE, DIBASIC ORAL; SOLUTION
POTASSIUM PHOSPHATE, DIBASIC ORAL; SUSPENSION
POTASSIUM PHOSPHATE, DIBASIC ORAL; SYRUP
POTASSIUM PHOSPHATE, DIBASIC ORAL; TABLET
POTASSIUM PHOSPHATE, DIBASIC SUBCUTANEOUS; INJECTION
POTASSIUM PHOSPHATE, DIBASIC SUBCUTANEOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
POTASSIUM PHOSPHATE, MONOBASIC AN,INFILTRATION; INJECTION
POTASSIUM PHOSPHATE, MONOBASIC AURICULAR (OTIC); SOLUTION
POTASSIUM PHOSPHATE, MONOBASIC IM - IV; INJECTION
POTASSIUM PHOSPHATE, MONOBASIC INTRA-ARTICULAR; INJECTION
POTASSIUM PHOSPHATE, MONOBASIC INTRAMUSCULAR; INJECTABLE
POTASSIUM PHOSPHATE, MONOBASIC INTRAMUSCULAR; INJECTION
POTASSIUM PHOSPHATE, MONOBASIC INTRAUTERINE; SOLUTION
POTASSIUM PHOSPHATE, MONOBASIC INTRAVENOUS; INJECTABLE
POTASSIUM PHOSPHATE, MONOBASIC INTRAVENOUS; INJECTION
POTASSIUM PHOSPHATE, MONOBASIC IV(INFUSION); SOLUTION, INJECTION
POTASSIUM PHOSPHATE, MONOBASIC NASAL; SPRAY
POTASSIUM PHOSPHATE, MONOBASIC NERVE BLOCK; INJECTION
POTASSIUM PHOSPHATE, MONOBASIC OPHTHALMIC; SOLUTION
POTASSIUM PHOSPHATE, MONOBASIC OPHTHALMIC; SOLUTION, DROPS
POTASSIUM PHOSPHATE, MONOBASIC OPHTHALMIC; SUSPENSION
POTASSIUM PHOSPHATE, MONOBASIC ORAL; CAPSULE, ENTERIC COATED PELLETS
POTASSIUM PHOSPHATE, MONOBASIC ORAL; SOLUTION
POTASSIUM PHOSPHATE, MONOBASIC ORAL; SUSPENSION
POTASSIUM PHOSPHATE, MONOBASIC ORAL; SYRUP
POTASSIUM PHOSPHATE, MONOBASIC ORAL; TABLET
POTASSIUM PHOSPHATE, MONOBASIC ORAL; TABLET, SUSTAINED ACTION
POTASSIUM PHOSPHATE, MONOBASIC SUBCUTANEOUS; POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
POTASSIUM POLACRILIN ORAL; TABLET
POTASSIUM POLACRILIN ORAL-21; TABLET
POTASSIUM SOAP TOPICAL; SOLUTION
POTASSIUM SORBATE NASAL; SPRAY, METERED
POTASSIUM SORBATE OPHTHALMIC; SOLUTION
POTASSIUM SORBATE ORAL; CAPSULE
POTASSIUM SORBATE ORAL; CONCENTRATE
POTASSIUM SORBATE ORAL; GRANULE, FOR SUSPENSION
POTASSIUM SORBATE ORAL; POWDER, FOR SUSPENSION
POTASSIUM SORBATE ORAL; SOLUTION
POTASSIUM SORBATE ORAL; SUSPENSION
POTASSIUM SORBATE ORAL; SYRUP
POTASSIUM SORBATE ORAL; TABLET
POTASSIUM SORBATE ORAL; TABLET, SUSTAINED RELEASE, FILM COATED
POTASSIUM SORBATE RECTAL; SOLUTION
POTASSIUM SORBATE TOPICAL; EMULSION, CREAM
POTASSIUM SORBATE TOPICAL; LOTION
POTASSIUM SORBATE TOPICAL; SOLUTION
POVIDONE HYDROGEL TRANSDERMAL; PATCH, CONTROLLED RELEASE
POVIDONE K17 SUBCUTANEOUS; SUSPENSION, INJECTION
POVIDONE K25 ORAL; CAPSULE
POVIDONE K25 ORAL; CAPSULE, EXTENDED RELEASE
POVIDONE K25 ORAL; CAPSULE, SUSTAINED ACTION
POVIDONE K25 ORAL; CAPSULE, SUSTAINED ACTION, HARD GELATIN
POVIDONE K25 ORAL; SOLUTION
POVIDONE K25 ORAL; TABLET
POVIDONE K25 ORAL; TABLET, DELAYED ACTION, ENTERIC COATED
POVIDONE K25 ORAL; TABLET, FILM COATED
POVIDONE K25 ORAL; TABLET, MULTILAYER, EXTENDED RELEASE
POVIDONE K25 ORAL; TABLET, SUSTAINED ACTION, COATED
POVIDONE K26/28 ORAL; TABLET
POVIDONE K29-32 OPHTHALMIC; SOLUTION

First Page Previous Page Next Page Last Page




Last Modified: 29 April 2006
http://www.biomaterials.info
Sitemap
Link | Link | Link | Link | Link | Link | Link | Link